Alira Health

Alira Health

CPHI Barcelona

October 24-26 | Barcelona, Spain

We are pleased to announce that we will attend CPHI at Barcelona. This event gathers thousands of industry leaders under one roof and brings endless opportunities to learn, innovate, and develop meaningful connections.

Connect with our experts and learn how can we design tailor-made solutions to achieve your business goals at every step of the way, from transaction advisory services to market access, pricing, and reimbursement strategies.

Published on:
October 15, 2023
Our Delegates

Alexandra Wollersheim

Partner, Transaction Advisory

Shaneze Chebbah

Principal, Transaction Advisory

Camille Abdelaziz

Manager, Transaction Advisory

Nerea Blanqué-Catalina

Managing Partner, Consulting Affiliates
Chus Castillo

Chus Castillo

Partner, Consulting Iberia
Jordi Hernandez

Jordi Hernández

Principal, Consulting Small Pharma & Biotech
Nicola Luise

Nicola Luise

Senior Consultant, Consulting Small Pharma & Biotech

Related news

Articles July 4, 2024
Navigating Market Access for Rare Diseases: The Potential of Real-World Evidence
Our experts answer common questions about the strategic need for real-world evidence to drive market access for rare diseases.
Market Access Rare Disease Real-World Evidence (RWE)
Case Studies June 27, 2024
A Multinational Pharma Targeting Myasthenia Gravis Garners Payer Advice on Market Access
Our client sought to incorporate early payer advice on the MG clinical trial design, identify evidence gaps, and provide insights on the overall development program for the asset.
Market Access Myasthenia Gravis (MG) Rare Disease
Articles March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
News February 7, 2024
Alira Health Advises Aesculapius Farmaceutici Srl in Its Acquisition by Ceres Pharma NV
We are pleased to have represented as transaction advisor Aesculapius, a leading Italian pharmaceutical company active in the development and distribution of prescription drugs, OTC(...)
Pharma Transaction Advisory
Events February 1, 2024
2023 BioRegion Report Presentation
Biotech Spain
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.